+44 1300 500008Clinical & Experimental Cardiology : Citations & Metrics Report
Articles published in Clinical & Experimental Cardiology have been cited by esteemed scholars and scientists all around the world. Clinical & Experimental Cardiology has got h-index 14, which means every article in Clinical & Experimental Cardiology has got 14 average citations.
Following are the list of articles that have cited the articles published in Clinical & Experimental Cardiology.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
56 | 111 | 60 | 56 | 72 | 27 | 53 | 76 | 88 | 61 | 73 | 136 | 96 | 61 | 13 |
Research, Review articles and Editorials |
6 | 9 | 6 | 24 | 42 | 20 | 39 | 53 | 59 | 39 | 52 | 99 | 75 | 38 | 9 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
44 | 102 | 54 | 32 | 30 | 7 | 14 | 23 | 29 | 22 | 21 | 37 | 21 | 23 | 4 |
Conference proceedings |
18 | 25 | 41 | 43 | 3 | 49 | 398 | 389 | 515 | 204 | 157 | 126 | 26 | 33 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
143 | 212 | 54 | 63 | 88 | 70 | 62 | 294 | 304 | 211 | 147 | 75 | 29 | 93 | 0 |
| Journal total citations count | 2980 |
| Journal impact factor | 1.05 |
| Journal 5 years impact factor | 1.27 |
| Journal cite score | 1.34 |
| Journal h-index | 14 |
| Journal h-index since 2019 | 9 |
Important citations (1711)
Jazbutyte v. specific, robust, reproducible: the hunt for the ideal biomarker. j. clin. exp. cardiol. 2012;1:9880. |
|
Price kj, gordon ba, bird sr, benson ac. is the clinical delivery of cardiac rehabilitation in an australian setting associated with changes in physical capacity and cardiovascular risk and are any changes maintained for 12 months?. international journal of environmental research and public health. 2021 jan;18(17):8950. |
|
Lantto ta. cytotoxic and apoptotic effects of selected phenolic compounds and extracts from edible plants. |
|
Devidutta s, yeo kk. acute stent thrombosis due to stent underexpansion managed with rotational atherectomy. cardiovascular revascularization medicine. 2016 jan 1;17(1):66-70. |
|
Sainova iv, pavlova vg, alexieva bs, valkova ip, ilieva in, nikolova eb. attenuation of cellular oxidative stress by natural products and plant extracts after chemotherapeutic exposure. journal of bioscience & biotechnology. 2015 sep 2. |
|
Rawat ps, jaiswal a, khurana a, bhatti js, navik u. doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management. biomedicine & pharmacotherapy. 2021 jul 1;139:111708. |
|
Shi c, wu h, xu k, cai t, qin k, wu l, cai b. liquiritigenin-loaded submicron emulsion protects against doxorubicin-induced cardiotoxicity via antioxidant, anti-inflammatory, and anti-apoptotic activity. international journal of nanomedicine. 2020;15:1101. |
|
Akbari s, kariznavi e, jannati m, elyasi s, tayarani-najaran z. curcumin as a preventive or therapeutic measure for chemotherapy and radiotherapy induced adverse reaction: a comprehensive review. food and chemical toxicology. 2020 aug 25:111699. |
|
Shi w, deng h, zhang j, zhang y, zhang x, cui g. mitochondria-targeting small molecules effectively prevent cardiotoxicity induced by doxorubicin. molecules. 2018 jun;23(6):1486. |
|
Pizarro m, troncoso r, martínez gj, chiong m, castro pf, lavandero s. basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity. toxicology. 2016 aug 31;370:41-8. |
|
Zhang ql, yang jj, zhang hs. carvedilol (car) combined with carnosic acid (caa) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy. biomedicine & pharmacotherapy. 2019 jan 1;109:71-83. |
|
Hashemzaei m, heravi re, rezaee r, roohbakhsh a, karimi g. regulation of autophagy by some natural products as a potential therapeutic strategy for cardiovascular disorders. european journal of pharmacology. 2017 may 5;802:44-51. |
|
Mohajeri m, sahebkar a. protective effects of curcumin against doxorubicin-induced toxicity and resistance: a review. critical reviews in oncology/hematology. 2018 feb 1;122:30-51. |
|
Saito h, suda t, nishida y. guidewire knot formation with peripherally inserted central catheter. clinical case reports. 2021 feb;9(2):1035-6. |
|
Shabalala s, muller cj, louw j, johnson r. polyphenols, autophagy and doxorubicin-induced cardiotoxicity. life sciences. 2017 jul 1;180:160-70. |
|
Khattab om. health-related quality of life among post myocardial infarction patients at governmental hospitals in the gaza strip ???? ????? ???? ?????? ??? ?? ???? ??? ?????? ???????? ?????? (doctoral dissertation, islamic university of gaza). |
|
Bartlett jj, trivedi pc, pulinilkunnil t. autophagic dysregulation in doxorubicin cardiomyopathy. journal of molecular and cellular cardiology. 2017 mar 1;104:1-8. |
|
Kumar g, mittal s, sak k, tuli hs. molecular mechanisms underlying chemopreventive potential of curcumin: current challenges and future perspectives. life sciences. 2016 mar 1;148:313-28. |
|
Renu k, abilash vg, pb tp, arunachalam s. molecular mechanism of doxorubicin-induced cardiomyopathy–an update. european journal of pharmacology. 2018 jan 5;818:241-53. |
|
Bis j, go?ci?ska-bis k, gardas r, morkisz ?, goco? r, kowalówka a, go?ba ks, deja ma. combined procedure involving thoracoscopic implantation of the epicardial left ventricular lead and removal of the his bundle pacing lead in a patient with heart failure. kardiologia polska (polish heart journal). 2020;78(11):1183-4. |
|